People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Other Health Care, Healthtech, Biotechnology, Pharmaceuticals, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Veran Medical Technologies, Inc. | — | Other Health Care | Series C | $130.9M | $953.8M | 2013 |
| Francis Medical, Inc. | — | Healthtech | Series B | $70.1M | $233.8M | 2018 |
| Basking Biosciences, Inc. | — | Biotechnology | Series B | $29.4M | $261.0M | 2023 |
| Aerial Biopharma, Llc | — | Pharmaceuticals | Series A | $27.2M | $294.2M | 2011 |
| I-O Urology Corp | — | Other | Series B | $16.0M | $113.1M | 2023 |
| NX Prenatal Inc. | — | Other Health Care | Series A | $8.6M | $24.1M | 2020 |
| Biostable Science & Engineering Inc | — | Other Technology | Series A | $4.2M | $115.6M | 2020 |
David Adair at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Adair on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Saunders | 1 | 18 |
| Steve Gillis | 1 | 13 |
| Greg Johnson | 1 | 9 |
| Jan Garfinkle | 1 | 7 |
| John Green | 1 | 5 |
| Joe Cunningham | 1 | 5 |
| Richard Shea | 1 | 5 |
| Andrew Cleeland | 1 | 5 |
| MOISE KHAYRALLAH | 1 | 5 |
| Ryan Helon | 1 | 5 |
| Mary Lake Polan | 1 | 4 |
| Brian Brohman | 1 | 4 |
| Gail Page | 1 | 4 |
| Michael Hoey | 1 | 4 |
| Thomas Needham | 1 | 4 |
| David Strong | 1 | 3 |
| Ajit Shah | 1 | 3 |
| STEPHEN BUTTS | 1 | 3 |
| Jeremy R. Degenhart | 1 | 3 |
| Dan Myers | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.